Cargando…

YTHDF1 Aggravates the Progression of Cervical Cancer Through m(6)A-Mediated Up-Regulation of RANBP2

N6-methyladenosine (m(6)A) is the most common post-transcriptional modification of RNA in eukaryotes, which has been demonstrated to play important roles in various cancers. YTHDF1 acts as a crucial m(6)A “reader” and regulates the fate of m(6)A modified mRNA. However, its role in cervical cancer re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Haocheng, Luo, Qingya, Kang, Jianyi, Wei, Qinglv, Yang, Yu, Yang, Dan, Liu, Xiaoyi, Liu, Tao, Yi, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017305/ https://www.ncbi.nlm.nih.gov/pubmed/33816306 http://dx.doi.org/10.3389/fonc.2021.650383

Ejemplares similares

Upregulation of LRRC8A by m(5)C modification-mediated mRNA stability suppresses apoptosis and facilitates tumorigenesis in cervical cancer
por: Chen, Yanjie, et al.
Publicado: (2023)

The m(6)A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
por: Liu, Tao, et al.
Publicado: (2020)

Exploration of the Role of m(6) A RNA Methylation Regulators in Malignant Progression and Clinical Prognosis of Ovarian Cancer
por: Wei, Qinglv, et al.
Publicado: (2021)

Prognostic and predictive value of YTHDF1 and YTHDF2 and their correlation with tumor-infiltrating immune cells in non-small cell carcinoma
por: Koh, Young Wha, et al.
Publicado: (2022)

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma
por: Mu, Zhongyi, et al.
Publicado: (2020)

YTHDF1 promotes mRNA degradation via YTHDF1‐AGO2 interaction and phase separation
por: Li, Jiong, et al.
Publicado: (2021)

YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma
por: Bai, Yang, et al.
Publicado: (2019)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

NAT10-mediated RNA acetylation enhances HNRNPUL1 mRNA stability to contribute cervical cancer progression
por: Long, Yingfei, et al.
Publicado: (2023)

Potential Impact of ALKBH5 and YTHDF1 on Tumor Immunity in Colon Adenocarcinoma
por: Yan, Guanyu, et al.
Publicado: (2021)

Methyltransferase-like 3 aggravates endoplasmic reticulum stress in preeclampsia by targeting TMBIM6 in YTHDF2-dependent manner
por: Chen, Yangyang, et al.
Publicado: (2023)

Research progress on the relationship between m(6)A methylation of YTHDF1 gene in the striatum and stereotyped behavior
por: Wen, Xiaohan, et al.
Publicado: (2022)

RanBP9 aggravates synaptic damage in the mouse brain and is inversely correlated to spinophilin levels in Alzheimer's brain synaptosomes
por: Palavicini, J P, et al.
Publicado: (2013)

The RNA binding protein QKI5 suppresses ovarian cancer via downregulating transcriptional coactivator TAZ
por: Liu, Tao, et al.
Publicado: (2021)

RANBP10 promotes glioblastoma progression by regulating the FBXW7/c-Myc pathway
por: Hou, Jianbing, et al.
Publicado: (2021)

m(6)A facilitates YTHDF‐independent phase separation
por: Liu, Si‐Yu, et al.
Publicado: (2019)

YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner
por: Chen, Hengyu, et al.
Publicado: (2022)

Immune checkpoint inhibitors in cervical cancer: Current status and research progress
por: Xie, Yunkai, et al.
Publicado: (2022)

SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m(6)A-modified mRNAs
por: Hou, Guofang, et al.
Publicado: (2021)

RanBP3 Regulates Proliferation, Apoptosis and Chemosensitivity of Chronic Myeloid Leukemia Cells via Mediating SMAD2/3 and ERK1/2 Nuclear Transport
por: Li, Qian, et al.
Publicado: (2021)

Surgical Staging of Locally Advanced Cervical Cancer: Current Status and Research Progress
por: Zhang, He, et al.
Publicado: (2022)

RanBP9 at the intersection between cofilin and Aβ pathologies: rescue of neurodegenerative changes by RanBP9 reduction
por: Woo, J A, et al.
Publicado: (2015)

Progression in immunotherapy for advanced prostate cancer
por: Liang, Hao, et al.
Publicado: (2023)

RanBP2 Modulates Cox11 and Hexokinase I Activities and Haploinsufficiency of RanBP2 Causes Deficits in Glucose Metabolism
por: Aslanukov, Azamat, et al.
Publicado: (2006)

m(6)A binding protein YTHDF2 in cancer
por: Chen, Xiaomin, et al.
Publicado: (2022)

CD155 Promotes the Progression of Cervical Cancer Cells Through AKT/mTOR and NF-κB Pathways
por: Liu, Lu, et al.
Publicado: (2021)

The N6-Methyladenosine (m6A) Methylation Gene YTHDF1 Reveals a Potential Diagnostic Role for Gastric Cancer
por: Liu, Tong, et al.
Publicado: (2020)

YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1–RPN2–PI3K/AKT/mTOR Axis
por: Zhu, Junlong, et al.
Publicado: (2023)

Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis
por: Xu, Peng, et al.
Publicado: (2022)

RANBP9 suppresses tumor proliferation in colorectal cancer
por: Qin, Chunzhi, et al.
Publicado: (2019)

YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner
por: Liu, Xiangxiang, et al.
Publicado: (2020)

YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFβ1-SMAD2/3 Pathway
por: Zhao, Teng, et al.
Publicado: (2022)

High systemic immune-inflammation index predicts poor prognosis and response to intravesical BCG treatment in patients with urothelial carcinoma: a systematic review and meta-analysis
por: Liu, Wen, et al.
Publicado: (2023)

A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer
por: Hu, Haoran, et al.
Publicado: (2022)

ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1
por: Han, Zhenbo, et al.
Publicado: (2021)

Intense work-up is required for pediatric COVID-related acute necrotizing encephalopathy with RANBP2 variants
por: Finsterer, Josef, et al.
Publicado: (2023)

YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
por: Shi, Yulin, et al.
Publicado: (2019)

The m(6)A Readers YTHDF1 and YTHDF2 Synergistically Control Cerebellar Parallel Fiber Growth by Regulating Local Translation of the Key Wnt5a Signaling Components in Axons
por: Yu, Jun, et al.
Publicado: (2021)

Binding to m(6)A RNA promotes YTHDF2-mediated phase separation
por: Wang, Jiahua, et al.
Publicado: (2019)

Correction to: Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis
por: Xu, Peng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iton63s8hlhgb256ki9lnd2l04